These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1020068)

  • 41. Should recurrent calcium oxalate stone formers become vegetarians?
    Robertson WG; Peacock M; Heyburn PJ; Hanes FA; Rutherford A; Clementson E; Swaminathan R; Clark PB
    Br J Urol; 1979 Dec; 51(6):427-31. PubMed ID: 534817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium is neither a risk nor a protective factor in urolithiasis?
    Singh PP; Pendse AK; Hada P; Nagori PC; Rathore V; Dashora PK
    Urol Res; 1987; 15(2):105-8. PubMed ID: 3590427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Supersaturated urine.
    Lancet; 1979 Jun; 1(8128):1219-20. PubMed ID: 87681
    [No Abstract]   [Full Text] [Related]  

  • 44. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary ionic calcium and binding sites in normocalciuric idiopathic calcium urolithiasis.
    Jacobson AL; Singhal PC; Mandin H; Hyne JB
    Invest Urol; 1979 Nov; 17(3):218-22. PubMed ID: 500320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medical treatment of idiopathic calcium lithiasis (II)].
    Bataille P; Finet M; Renaud H; Fievet P; Rogez JC; Fournier A
    Nephrologie; 1985; 6(4):195-202. PubMed ID: 2418378
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
    Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seasonal variation in urinary excretion of calcium, oxalate, magnesium and phosphate on free and standard mineral diet in men with urolithiasis.
    Juuti M; Heinonen OP; Alhava EM
    Scand J Urol Nephrol; 1981; 15(2):137-41. PubMed ID: 7330607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.
    Nicar MJ; Peterson R; Pak CY
    J Urol; 1984 Mar; 131(3):430-3. PubMed ID: 6699979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A biochemical basis for grouping of patients with urolithiasis.
    Tiselius HG; Almgård LE; Larsson L; Sörbo B
    Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High fluid intake or pharmacological therapy in recurrent stone former patients?
    Aroldi A; Graziani G; Passerini P; Castelnovo C; Mandressi A; Trinchieri A; Colussi G; Ponticelli C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():743-6. PubMed ID: 3991571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idiopathic hypercalciuria in calcium nephrolithiasis.
    Coe FL; Favus MJ
    Dis Mon; 1980 Sep; 26(12):1-36. PubMed ID: 6905773
    [No Abstract]   [Full Text] [Related]  

  • 58. Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria.
    Hautmann R; Hering FJ; Lutzeyer W
    J Urol; 1978 Dec; 120(6):712-5. PubMed ID: 731812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [14C]Oxalate absorption by normal persons, calcium oxalate stone formers, and patients with surgically disturbed intestinal function.
    Tiselius HG; Ahlstrand C; Lundström B; Nilsson MA
    Clin Chem; 1981 Oct; 27(10):1682-5. PubMed ID: 7285319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.